Previous achievements
Discover CeeD's presentations and posters.
PRESENTATIONS
2023
European Association for the Study of Diabetes (EASD), Hambourg, Germany, October 2023
Unique signature of circular RNA in skeletal muscle of different insulin sensitivity, M. Yepmo
IPITA, San Diego, USA, October 2023
ILV-001 a highly promising therapeutic agent for islet transplantation. A. Langlois, A. Grabarz, M. Pinget, K. Bouzakri.
Société Francophone du Diabète (SFD), Montpellier, France, March 2023
Peptide X, un inhibiteur de la protéine MP001 prometteur pour améliorer la survie et la fonction des îlots pancréatiques humains. A. Langlois, M. Kanzaki, G. Bechtluft, M. Pinget, K. Bouzakri.
2022
EASD, Stockholm, Sweden, September 2022
Peptide X, a promising inhibitor of MP001 protein which improves human pancreatic islet survival and function. A. Langlois, M. Kanzaki, G. Bechtluft, M. Pinget, K. Bouzakri
2021
Société Francophone du Diabète (SFD), Strasbourg, France, March 2021
Un composant du sécrétome musculaire au secours de la greffe d’îlots pancréatiques. A. Langlois, W. Bietiger, C. Peronet, G. Bechtluft, M. Pinget, K. Bouzakri.
2017
IPITA, Oxford, UK, June 2017
Improvement of pancreatic islet survival, function and angiogenesis targeting Prolylhydroxylases. A. Langlois, W. Bietiger; C. Peronet, C. Sookhareea, C. Mura; E. Maillard, M. Pinget, S. Sigrist and K. Bouzakri.
2016
Transplantation Research & Techniques, Atlanta, USA, October 2016
Stimulation of islet revascularization modulating HIF-1α expression using siPHD3. A. Langlois, E. Maillard-Pedracini, M. Prinz, R. Beaurepère, W. Bietiger, C. Sookhareea, C. Mura, N. Jeandidier1, M. Pinget, S. Sigrist.
2014
AIDPIT, Igls, Austria, January 2014
Pro-angiogenic effect of liraglutide in a model of intrahepatic transplantation of rat pancreatic islets: role of oxidative stress. A. Langlois, S. Dal-Ros, K. Vivot, W. Bietiger, C. Mura, C. Peronet, E. Seyfritz, C. Dollinger, E. Maillard, M. Pinget, N. Jeandidier, S. Sigrist.
2013
IPITA, Monterey, USA, September 2013
Role of oxidative stress in the pro-angiogenic effect of liraglutide on Rat pancreatic islets. A. Langlois, S. Dal-Ros, W. Bietiger, C. Mura, E. Seyfritz, C. Dollinger, M. Pinget, N. Jeandidier, S. Sigrist.
2011
CTS-IXA, Miami, USA, October 2011
- Stimulation of VEGF secretion in rat pancreatic islets using Liraglutide. A. Langlois, K. Vivot, N. Jeandidier, W. Bietiger, C. Dollinger, M. Pinget, S. Sigrist
- Influence of islet culture on angiogenic and inflammatory reaction. A. Langlois, K. Vivot, N. Jeandidier, C. Dollinger, W. Bietiger, M. Pinget, S. Sigrist
IPITA, Prague, Czech Republic, June 2011
Role of islet culture on angiogenic and inflammatory mechanisms. A. Langlois, C. Dollinger , W. Bietiger , K. Vivot , N. Jeandidier , M. Pinget, S. Sigrist.
2010
Alfediam - Société Francophone du Diabète (SFD), Lille, France, March 2010
Effet comparé de la surexpression du VEGF par la Deferoxamine ou l’infection adénovirale sur le contrôle métabolique de rats diabétiques après transplantation d’îlots pancréatiques. A. Langlois, W. Bietiger, M. Pinget, L. Kessler, N. Jeandidier, S. Sigrist.
AIDPIT, Igls, Austria, January 2010
- Identification of new therapeutic targets to increase islet vascularization during transplantation. A. Langlois, W. Bietiger, M. Pinget, S. Sigrist.
- Comparative effect of VEGF overexpression using DFO or adenoviral infection on metabolic control of diabetic Rats after islets transplantation. A. Langlois, W. Bietiger, M. Pinget, L. Kessler, N. Jeandidier, S. Sigrist.
2009
Alfediam - Société Francophone du Diabète (SFD), Strasbourg, France, March 2009
Amélioration de la revascularisation des îlots pancréatiques après transplantation : approche génétique ou pharmacologique ? A. Langlois, W. Bietiger, E. Seyfritz, E. Maillard, A. Belcourt, M. Pinget, L. Kessler, S. Sigrist.
ATTD, Athens, Greece, February 2009
Optimization of pancreatic islets revascularization after transplantation: Pharmacological approach or gene therapy? A. Langlois, W. Bietiger, E. Seyfritz, E. Maillard, A. Belcourt, M. Pinget, L. Kessler, S. Sigrist.
2008
Alfediam - Société Francophone du Diabète (SFD), Brussels, Belgium, March 2008
Approche pharmacologique ou génique pour la surexpression du VEGF par les îlots pancréatiques au cours de la transplantation ? A. Langlois, W. Bietiger, E. Seyfritz, K. Mandes, E. Maillard, A. Belcourt, M. Pinget, L. Kessler, S. Sigrist.
AIDPIT, Igls, Austria, January 2008
Pharmacologic approach or gene therapy for VEGF overexpression in pancreatic islets during transplantation? A. Langlois, W. Bietiger, E. Seyfritz, K. Mandes, E. Maillard, A. Belcourt, M. Pinget, L. Kessler, S. Sigrist.
2007
IPITA, Minneapolis, USA, September 2007
Overexpression of VEGF in vitro using deferoxamine: new drug to increase islet vascularisation during transplantation. A. Langlois, W. Bietiger, K. Mandes, E. Maillard, M. Pinget, L. Kessler, S. Sigrist.
International Symposium Bioengineering and Regenerative Medicine, Mulhouse, France, September 2007
Overexpression of VEGF in vitro using deferoxamine: new drug to increase islet vascularisation during transplantation. A. Langlois, W. Bietiger, K. Mandes, E. Maillard, M. Pinget, L. Kessler, S. Sigrist.
AIDPIT, Montpellier, France, February 2007
Effect of the deferoxamine in the overexpression of VEGF during islets transplantation. A. Langlois, K. Mandes, A. Belcourt, M. Pinget, L. Kessler, S. Sigrist.
2006
Alfediam - Société Francophone du Diabète (SFD), Paris, France, March 2006
Surexpression de VEGF au cours de la transplantation d’îlots : thérapie génique ou cellulaire ? A. Langlois, K. Mandes, A. Belcourt, M. Pinget, L. Kessler, S. Sigrist,
AIDPIT, Pisa, Italy, February 2006
Cellular or gene therapy for type 1 diabetic patients: Overexpression of VEGF during islets transplantation. A. Langlois, K. Mandes, A. Belcourt, M. Pinget, L. Kessler, S. Sigrist.
TONECA, Barcelona, Spain, January 2006
Preservation of islets viability during transplantation: vegf overexpression using cellular or gene therapy. A. Langlois, K. Mandès, A. Belcourt, M. Pinget, L. Kessler, S. Sigrist.
POSTERS
2023
American Diabetes Association (ADA), San Diego, USA, June 2023
• ILV-001 a highly promising therapeutic agent for islet transplantation. A. Langlois, A. Grabarz, M. Pinget, K. Bouzakri.
• Unique signature of circular RNA in skeletal muscle of different insulin sensitivity. M. Yepmo, E. Meugnier, M. Pinget, K. Bouzakri
Société Francophone du Diabète (SFD), Montpellier, France, March 2023
Résultats d’un dépistage de masse du diabète de type 2 chez 8 354 sujets vivant dans le Grand Est entre 2015 et 2021. M. Pflieger, R. Bidani, S. Ludwig, D. Gras, M. Pinget
2022
Société Française d'Endocrinologie (SFE), Nantes, France, October 2022
Prévention et traitement de la NASH par des myokines. A. Dumond Bourie, JB Potier, A. Fardellas, M. Aouadi et K. Bouzakri
International Liver Congress, European Association for the Study of Liver, London, UK, June 2022
Skeletal muscle-derives myokine affects insulin sensitivity and lipogenesis in a human hepatocytes spheroid model. A. Dumond, J-B. Potier, M. Aouadi, A. Fardellas
Société Francophone du Diabète (SFD), Nice, France, March 2022
La Myokine X, myokine dérivée du triceps, protège les cellules β pancréatiques contre l'inflammation chronique. A. Langlois, B. Zarrouki, J. Cherfan, C. Arous, C. Peronet, H. Hamdard, B. Wehrle Haller, M. Pinget et K. Bouzakri.
2019
EuroDia Meeting, Strasbourg, France, November 2019
- Myokine X, a new candidate to improve pancreatic islet survival, function and angiogenesis during transplantation. A. Langlois, G. Desmartin, W. Bietiger, M. Pinget, K. Bouzakri.
- Use of targeted mRNA-loaded Extracellular Vesicles (EVs) for the specific delivery to cells and tissue. A. Forterre, JH Wang, A. Delcayre, K. Kim, C. Green, M. D. Pegram, S. S. Jeffrey and AC Matin.
- Insulin-resistance induced TNF-alpha in C2C12 increase the release of exosome-like vesicles which affect insulin of pancreatic beta-cells. L. Reininger, A. Jalabert, JP Pais de Barros, V. Bergas, P. Colosetti, N. Akbar, R. Choudhury, M. Pinget, M. L Mizgier, K. Bouzakri and S. Rome
- Regulation of exosomes secretion by muscle fiber and insulin sensitivity. ML Mizgier, H Hamdard, M Pinget, K Bouzakri
- Preliminary results on the effect of M101, a marine oxygen carrier, on human pancreases cold preservation. F. Lemaire, C. Peronet, K.Bouzakri, S. Sigrist, E. Delpy, F. Zal, M.Pinget and E. Maillard
2017
EuroDia Meeting, Strasbourg, France, November 2017
Improvement of pancreatic islet survival, function and angiogenesis targeting Prolylhydroxylases. A. Langlois, W. Bietiger; C. Peronet, C. Sookhareea, C. Mura; E. Maillard, M. Pinget, S. Sigrist and K. Bouzakri.
EASD, Lisbon, Portugal, September 2017
Impact of Prolyhydroxylases proteins on survival, function and angiogenesis in pancreatic islets: A target to improve islets graft? A. Langlois, W. Bietiger; C. Peronet, C. Sookhareea, C. Mura; E. Maillard, M. Pinget, S. Sigrist and K. Bouzakri.
2016
EPITA, Igls, Austria, Janvier 2016
Impact of hyperglycemia on islets revascularization deficiency post intraportale transplantation. A. Langlois , E. Maillard-Pedracini , S. DAL, C. Sookhareea, A. Schaschkow , W. Bietiger, N. Jeandidier, M. Pinget, S. Sigrist
2015
IPITA, Melbourne, Australia, November 2015
- Impact of hyperglycemia on islets revascularization deficiency post intraportale transplantation. A. Langlois, S. DAL, C. Sookhareea, A. Schaschkow , E. Maillard-Pedracini, W. Bietiger, N. Jeandidier, M. Pinget, S. Sigrist
- Stimulation of islet revascularization modulating HIF-1α expression using siPHD3. A. Langlois, E. Maillard-Pedracini, M. Prinz, R. Beaurepère, C. Mura, W. Bietiger, N. Jeandidier, M. Pinget, S. Sigrist
- New strategy of islet viability improvement in bioartificial pancreas using composites islets/MSC-A. A. Langlois, A. Grunenberg, E. Maillard-Pedracini, C. Mura, W. Bietiger, N. Jeandidier, M. Pinget, S. Sigrist.
2014
Société Francophone du Diabète (SFD), Paris, France, March 2014
- Effet pro-angiogénique du liraglutide dans un modèle de transplantation intra-hépatique d’îlots pancréatique de Rat: rôle du stress oxydant. A. Langlois, S. Dal-Ros, K. Vivot, W. Bietiger, C. Mura, C. Peronet, E. Seyfritz, C. Dollinger, E. Maillard, M. Pinget, N. Jeandidier, S. Sigrist.
- Evaluation des propriétés anti-inflammatoire et anti-oxydante du liraglutide sur des îlots pancréatiques de Rat in vitro. A. Langlois, K. Vivot, S. Dal-Ros, W. Bietiger, C. Mura, E. Seyfritz, C. Dollinger, M. Pinget, N. Jeandidier, S. Sigrist.
- Stratégies d’administration du liraglutide pour optimiser la transplantation d’îlots pancréatiques chez le Rat diabétique. A. Langlois, W. Bietiger, C. Mura, C. Peronet, E. Maillard, M. Pinget, N. Jeandidier, S. Sigrist.
AIDPIT, Igls, Austria, January 2014
- Evaluation of anti-inflammatory and anti-oxidative properties of liraglutide on Rat pancreatic islets in vitro. A. Langlois, K. Vivot, S. Dal-Ros, W. Bietiger, C. Mura, E. Seyfritz, C. Dollinger, M. Pinget, N. Jeandidier, S. Sigrist
- Strategies of liraglutide administration to optimize islet transplantation in diabetic rats. A. Langlois, W. Bietiger, C. Mura, C. Peronet, E. Maillard, M. Pinget, N. Jeandidier, S. Sigrist.
2013
EASD, Barcelone, Spain, September 2013
Role of oxidative stress in the pro-angiogenic effect of liragluitde on Rat pancreatic islets. A. Langlois, S. Dal-Ros, W. Bietiger, C. Mura, E. Seyfritz, C. Dollinger, M. Pinget , N. Jeandidier , S. Sigrist.
2012
Société Francophone du Diabète (SFD), Nice, France, March 2012
Stimulation de la sécrétion de VEGF dans les îlots pancréatiques de Rat par le Liraglutide. A. Langlois , K. Vivot , N. Jeandidier , W. Bietiger , C. Dollinger , M. Pinget , S. Sigrist.
2011
EASD, Lisbonne, Portugal, September 2011
Liraglutide increases VEGF secretion in rat pancreatic islets. A. Langlois, K. Vivot, N. Jeandidier, W. Bietiger, C. Dollinger, M. Pinget, S. Sigrist.
Société Francophone du Diabète (SFD), Geneva, Switzerland, March 2011
- Rôle favorable du temps de culture des îlots pancréatiques de Rat sur l’inflammation. A. Langlois, C. Dollinger, W. Bietiger, K. Vivot, N. Jeandidier, M. Pinget, S. Sigrist.
- Rôle délétère du temps de culture des îlots pancréatiques de Rat sur les mécanismes angiogéniques. A. Langlois, C. Dollinger, W. Bietiger, K. Vivot, N. Jeandidier, M. Pinget, S. Sigrist.
2010
Alfediam - Société Francophone du Diabète (SFD), Lille, France, March 2010
- Identification de nouvelles cibles pharmacologiques pour stimuler la revascularisation des îlots au cours de la transplantation. A. Langlois, W. Bietiger, M. Pinget, S. Sigrist.
- Inflammation et transplantation d’îlots pancréatiques : Rôle de la voie de chemokines. K. Vivot, A. Langlois, W. Bietiger, M. Pinget, L. Kessler, S. Sigrist.
- Etude des microparticules libérées par les cellules RINm5F soumises à différentes conditions de stress. F. Aboud, A. Langlois, JM. Freyssinet, L. Kessler, F. Toti-Orfanoudakis.
2009
IPITA, Venisa, Italy, October 2009
Identification of new therapeutic targets to increase islet vascularization during transplantation. A. Langlois, W. Bietiger, M. Pinget, S. Sigrist
AIDPIT, Igls, Austria, January 2009
Optimization of pancreatic islets revascularization after transplantation: pharmacological approach or gene therapy? A. Langlois, W. Bietiger, E. Seyfritz, E. Maillard, A. Belcourt, M. Pinget, L. Kessler, S. Sigrist
2008
EASD, Roma, Italy, September 2008
Optimization of pancreatic islets revascularization after transplantation: Pharmacological approach or gene therapy? A. Langlois, W. Bietiger, E. Seyfritz, K. Mandes, E. Maillard, A. Belcourt, M. Pinget, L. Kessler, S. Sigrist.
2007
Société française d'endocrinologie (SFE), Marseille, France, March 2007
Rôle de la déferoxamine dans la surexpression de VEGF au cours de la transplantation d’îlots. A. Langlois, K. Mandes, A. Belcourt, M. Pinget, L. Kessler, S. Sigrist.
2006
Alfediam - Société Francophone du Diabète (SFD), Paris, France, March 2006
Immunomodulation des îlots pancréatiques : effet de l’irradiation UVB sur l’activation macrophagique. A. Langlois, G. Guidicelli, K. Mandes, A. Belcourt, M. Pinget, L. Kessler, S. Sigrist.
AIDPIT, Pisa, Italy, February 2006
Immunomodulation of pancreatic islets: Effect of UVB irradiation on macrophage activation. A. Langlois, G. Guidicelli, K. Mandes, M. Pinget, L. Kessler, S. Sigrist.
2005
Société française d'endocrinologie (SFE), Strasbourg, France, October 2005
Immunomodulation des îlots pancréatiques : effet de l’irradiation UVB sur l’activation macrophagique. A. Langlois, G. Guidicelli, K. Mandes, M. Pinget, L. Kessler, S. Sigrist.
Our previous news
Since 1991, our scientific laboratory has been implementing a global strategy by developing tomorrow’s solutions to defeat diabetes.
Navigation
Contact & find us
Centre européen d'étude du Diabète (CeeD)
Boulevard René Leriche